Goorha Flashcards
What symptoms are common with pancytopenia?
- Fever
- Mouth sores
- Shortness of breath
What is the most common etiology of aplastic anemia?
Idiopathic
What are the mechanisms that cause pancytopenia?
- Bone marrow failure
- Destruction of blood cells in the peripheral blood
What is bone marrow failure?
- Pancytopenia due to the failure of bone marrow to produce blood cells -> includes low RBCs (anemia), WBCs (leukopenia), and platelets
1. Symptoms of anemia: difficulty breathing, chest pain, fatigue
2. Symptoms of leukopenia/neutropenia: fever, infection, mouth sores
3. Symptom of thrombocytopenia: bleeding
What is the differential diagnosis of pancytopenia?
- Increased destruction: immune destruction, sepsis, hypersplenism
- Decreased production: myelodysplasia, marrow infiltrate, B12 deficiency, aplastic anemia, drugs, viruses, radiation
What are some typical causes bone marrow failure via hypo- and hypercellular bone marrow?
- Hypocellular: aplastic anemia
1. Congenital: Fanconi
2. Acquired: ideopathic, myelodysplastic syn (more often hypercellular), drugs/chemicals, radiation, viruses - Hypercellular: bone marrow infiltration
1. Hematologic malignancies, carcinoma, storage disorders, myelodysplastic syndromes, B12 or folate deficiency
What is aplastic anemia?

- Severe, life-threatening syndrome in which production of erythrocytes, ABCs, and PLT has failed
- May occur in all age groups, both genders
- Characterized by peripheral pancytopenia, and accompanied by hypocellular bone marrow
What is a primary mechanism of idiopathic aplastic anemia?
- Immune-mediated destruction of hematopoietic stem cells
What is the pathophysiology of aplastic anemia?

- Primary defect is reduction in, or depletion of hematopoietic precursor stem cells with decreased production in all cell lines -> leads to PERIPHERAL PANCYTOPENIA
1. May be due to quant/qualitative damage to pluripotent stem cell
2. Result of defective bone marrow microenvo
3. Form of cellular/humoral immunosuppression of hematopoiesis
What are the 2 congenital disorders associated with aplastic anemia?
-
Fanconi’s anemia: chromosomal instability syndrome
1. Disorder usually becomes symptomatic at about 5 y/o and is associated with progressive bone marrow hypoplasia
2. Congenital defects like small stature and skin hyperpigmentation also seen in affected ppl - Familial aplastic anemia: subset of Fanconi’s in which congenital defects absent (can even present at later age, including in adulthood)
What are treatment options for aplastic anemia?
- Immunosuppression
- Stem cell transplant
- Transfusion
What are the acquired causes of aplastic anemia?
- Most common is idiopathic: no hx of exposures to substances known to be causative agents of disease
- Ionizing radiation: hematopoietic cells particularly susceptible to destruction (300-500 rads can wipe it out, but recovery with sublethal doses)
- Chemical agents: incl. those with benzene ring, chemo, and certain insecticides
- Idiosyncratic rxns to some drugs: like quinacrine or chloramphenicol (not commonly used anymore)
- Infections: viral/bac like mono, hepatitis, parvovirus, CMV, and miliary TB
- Pregnancy: rare
- PNH: stem cell disease (PIG-A) in which membranes of RBCs, WBCs, & PLTs have abnormality making them susceptible to complement-mediated lysis
What lab findings are associated with aplastic anemia?
- Severe pancytopenia with relative lymphocytosis (b/c they live a long time)
- Normochromic, normocytic RBCs (may be slightly macrocytic)
- Mild to moderate anisocytosis, poikilocytosis
- Decreased reticulocyte count (HALLMARK FINDING)
- Hypocellular bone marrow with >70% yellow marrow (predominantly fat)
What is the tx for aplastic anemia?
- Should include:
1. Withdrawal of potentially offending agents
2. Supportive care (e.g., transfusion, ABs)
3. Immunosuppressive regimens: anti-thymocyte globulin, cyclosporine, steroids often effective at improving counts -> suggests auto-immune destruction of hematopoietic stem cells a primary cause of idiopathic aplastic anemia
4. Hematopoietic stem cell transplantation - If there is a problem, look at the drugs your pt is on first (to see if they are causing the aplastic anemia)
What is pure red cell aplasia?
- Characterized by a selective decrease in erythroid precursor cells in bone marrow -> WBCs, platelets unaffected
-
Acquired:
1. Transitory with viral/bac infections
2. Pts w/hemolytic anemias may suddenly halt erythropoiesis
3. Pts w/thymoma: T-cell mediated responses against bone marrow erythroblasts or EPO sometimes produced (potential TEST QUESTION) - Treatment: supportive care and immunosuppression
What is the primary difference between myelodysplastic syndrome and aplastic anemia?
- Presence or absence of neoplastic cells in the bone marrow
In brief, what are MDS? What will you see in the bone marrow and peripheral smear?
-
Myelodysplastic syndromes: primary, neoplastic stem cell disorders that tend to terminate in acute leukemia
1. Bone marrow: normocellular, or hypercellular usually w/evidence of QUAL abnormalities in 1 or more cell lines -> ineffective erythropoiesis, granulopoiesis, and/or megakaryopoiesis
a. Ringed sideroblasts, o/dysplastic changes
2. Peripheral smear: dysplastic cells, including nucleated RBCs, oval macrocytes, pseudo-_Pelger-Huet PMNs_ (HYPO-segmented polys) w/hyper-chromatin clumping, hypo-granulated neutrophils, and giant bizarre platelets
What do you see here? What is this characteristic of?

- Pelger-Huet poly
- Commonly seen in MDS
- NOTE: there is also a congenital anomaly that causes abnormal segmentation of polys and no other side effects -> these people might be erroneously treated for infection due to “apparent left shift”
What are these? When might you see them?

- Ringed sideroblasts
- Commonly seen with MDS
What is the pathogenesis of MDS?
- Thought to arise from mutations in multi-potent bone marrow stem cell, but specific defects responsible for these diseases remain poorly understood
1. Differentiation of blood precursor cells impaired, and significant INC in levels of apoptotic cell death in marrow cells
2. Clonal expansion of abnormal cells causes production of cells with lost ability to differentiate (presence of a neoplastic clone differentiates from aplastic anemia) - If overall % of bone marrow blasts rises above 20% for WHO, 30% for FAB, then transformation to AML said to have occurred
What percentage of untreated MDS patients will develop AML?
90-95%
What is the treatment for MDS?
- Goals of therapy: to control symptoms, improve QOL, improve overall survival, and DEC progression to AML
- Supportive therapy w/blood product support and hematopoietic growth factors (i.e., EPO)
- Chemo w/hypo-methylating agents 5-azacytidine and decitabine (< toxic than older drugs; not entirely sure how they work, but may have to do w/de-methylation to allow differentiation) decreases blood transfusion requirements, slows progression to AML, INC survival
- Lenalidomide (5q), HSCT
What is lenalidomide? What is it used to treat?
- Approved in Dec, 2005 only for use in 5q syndrome (subset of MDS)
- Multiple MOA: in vitro -> direct anti-tumor effect, inhibition of angiogenesis, and immunomodulatory role; in vivo -> induces tumor cell apoptosis directly, indirectly via inhibition of bone marrow stromal cell support, anti-angiogenic and anti-osteoclastogenic effects, and immunomodulatory activity
- Broad range of activities that can be exploited to treat many hematologic and solid cancers
When is HSCT used to treat MDS? Why?

- Hematopoetic Stem cell transplantation
- In younger patients (<60 y/o), and more severely affected patients
- Offers the potential for curative therapy
- Has grown immensely in past several years
